Ari B Ginsparg, Jaqueline A Martinez, Ishaan Patel, Angélique Buton, Laura T Lee, Raheel Sarwar, Rocco Moretti, Stephanie Puig, Summer B Thyme
{"title":"Prioritizing neuroactive ligands using motif-guided virtual discovery and zebrafish profiling.","authors":"Ari B Ginsparg, Jaqueline A Martinez, Ishaan Patel, Angélique Buton, Laura T Lee, Raheel Sarwar, Rocco Moretti, Stephanie Puig, Summer B Thyme","doi":"10.1038/s44386-026-00058-1","DOIUrl":null,"url":null,"abstract":"<p><p>Virtual screening of ultra-large chemical libraries is a highly effective strategy for early-stage ligand discovery. However, these pipelines often yield thousands of molecules that pass computational filters, and in silico-derived interaction energies do not consistently predict experimental efficacy. Furthermore, many high-affinity hits do not necessarily function effectively in an organism with tissues, barriers, and extensive off-target possibilities. Here, we establish and apply an integrated pipeline that prioritizes candidate molecules through structure-guided computation and zebrafish-based functional profiling. We introduce Rosetta Engine for Anchoring Ligands with a Motif (\"REAL-M\"), a screening algorithm that uses structural interaction data from the Protein Data Bank (PDB) to guide ligand placement and selection. Using the hypocretin receptor as a test case, 28 of 30 predicted antagonists significantly blocked binding of the cognate peptide agonist in a cell-based reporter assay, including six chemically diverse molecules with efficacy comparable to preexisting antagonists. Three of these six significantly mitigated hypocretin-induced larval zebrafish hyperactivity. Secondary testing with a zebrafish hcrtr2 null mutant ensured that behavioral phenotypes were on target, in contrast to off-target phenotypes observed with a clinically approved antagonist. This pipeline is readily adaptable to the thousands of zebrafish proteins with highly conserved binding pockets.</p>","PeriodicalId":520448,"journal":{"name":"NPJ drug discovery","volume":"3 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2026-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13389409/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NPJ drug discovery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1038/s44386-026-00058-1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Virtual screening of ultra-large chemical libraries is a highly effective strategy for early-stage ligand discovery. However, these pipelines often yield thousands of molecules that pass computational filters, and in silico-derived interaction energies do not consistently predict experimental efficacy. Furthermore, many high-affinity hits do not necessarily function effectively in an organism with tissues, barriers, and extensive off-target possibilities. Here, we establish and apply an integrated pipeline that prioritizes candidate molecules through structure-guided computation and zebrafish-based functional profiling. We introduce Rosetta Engine for Anchoring Ligands with a Motif ("REAL-M"), a screening algorithm that uses structural interaction data from the Protein Data Bank (PDB) to guide ligand placement and selection. Using the hypocretin receptor as a test case, 28 of 30 predicted antagonists significantly blocked binding of the cognate peptide agonist in a cell-based reporter assay, including six chemically diverse molecules with efficacy comparable to preexisting antagonists. Three of these six significantly mitigated hypocretin-induced larval zebrafish hyperactivity. Secondary testing with a zebrafish hcrtr2 null mutant ensured that behavioral phenotypes were on target, in contrast to off-target phenotypes observed with a clinically approved antagonist. This pipeline is readily adaptable to the thousands of zebrafish proteins with highly conserved binding pockets.
超大化学文库的虚拟筛选是早期发现配体的有效策略。然而,这些管道通常产生数千个通过计算过滤器的分子,并且在硅中衍生的相互作用能量不能一致地预测实验效率。此外,许多高亲和力的撞击不一定在具有组织、屏障和广泛脱靶可能性的生物体中有效起作用。在这里,我们建立并应用了一个集成的管道,通过结构导向计算和基于斑马鱼的功能分析来优先考虑候选分子。我们介绍了Rosetta Engine for Anchoring Ligands with a Motif (REAL-M),这是一种筛选算法,它使用来自蛋白质数据库(PDB)的结构相互作用数据来指导配体的放置和选择。以下丘脑分泌素受体为例,在一项基于细胞的报告试验中,30种预测拮抗剂中有28种显著阻断了同源肽激动剂的结合,其中包括6种化学成分不同的分子,其疗效与现有拮抗剂相当。这六种药物中有三种可显著减轻下丘脑分泌素诱导的斑马鱼幼虫过度活跃。与临床批准的拮抗剂观察到的脱靶表型相比,斑马鱼hcrtr2零突变体的二次测试确保了行为表型的靶向性。这个管道很容易适应数千种具有高度保守结合口袋的斑马鱼蛋白质。